Breast fibroids, also known as fibrocystic breast illness, fibroid funbags, mammary dysplasia, benign breast illness and diffuse cystic mastopathy, are benign (non-cancerous), movable, rubbery nodules that cause painful swelling near the breast surface.
Breast Cancer Drug Effective for Fibroids in women
In premenopausal ladies with fibroids, the breast cancer drug anastrozole (Arimidex) reduces fibroid size and improves troublesome symptoms, according to results of a possible study conducted at the Aristotle University of Thessaloniki in Greece.
Fibroid tumors, or uterine leiomyomata, are benign growths in the uterus that may cause pain and bleeding and may at last require surgical removal.
Based on other studies, the analysts think long term treatment with anastrozole will be safe, but they stress that bigger, placebo-controlled medical trials will be necessary to establish the risk posed by prolonged anastrazole use in premenopausal women.
Anastrozole is usually prescribed for older (postmenopausal) ladies with breast cancer that is sensitive to estrogen. Anastrozole, and similar drugs, suppress the enzyme aromatase, which is needed to produce estrogen. The existing study indicates that anastrozole, given in such a small dose, acts basically by obstructing estrogens produced by the fibroids.
What are the factors behind Breast Fibroids?
The factors behind breast fibroids are not totally understood. However, there are several factors that play a serious role in the development of the illness.
* The monthly changes in the levels of oestrogen and progesterone are considered to be the most noteworthy factors making a contribution to this illness. These 2 hormones directly impact on the breast tissues by causing cells to grow and multiply.
* Prolactin, expansion factor, thyroid hormone and insulin also influence the development of breast fibroids.
* The breast produces hormonal products from its glandular and fat cells. These hormonal products send signals to the local breast cells. These signals are the key elements accountable for the development of breast fibroids.